Hassoun A, Linden PK, Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment. Crit Care. 2017;21:211.

Article  PubMed  PubMed Central  Google Scholar 

Liesenborghs L, Meyers S, Lox M, Criel M, Claes J, Peetermans M, et al. Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to damaged and inflamed heart valves. Eur Heart J. 2019;40:3248–59.

Article  PubMed  PubMed Central  Google Scholar 

Two-dose therapy for S. aureus bloodstream infections on par with standard treatment | National Institutes of Health (NIH). https://www.nih.gov/news-events/news-releases/two-dose-therapy-s-aureus-bloodstream-infections-par-standard-treatment. Retrieved 4 September 2025.

CDC. 2025. Antimicrobial resistance threats in the United States, 2021–2022. Antimicrobial resistance. https://www.cdc.gov/antimicrobial-resistance/data-research/threats/update-2022.html. Retrieved 17 July 2025.

Imani Fooladi AA, Ashrafi E, Tazandareh SG, Koosha RZ, Rad HS, Amin M, et al. The distribution of pathogenic and toxigenic genes among MRSA and MSSA clinical isolates. Microb Pathog. 2015;81:60–6.

Article  PubMed  CAS  Google Scholar 

Aratani T, Tsukamoto H, Higashi T, Kodawara T, Yano R, Hida Y, et al. Association of methicillin resistance with mortality of hospital-acquired Staphylococcus aureus bacteremia. J Int Med Res. 2021;49:3000605211058872.

Article  PubMed  CAS  Google Scholar 

Kourtis AP, Hatfield K, Baggs J, Mu Y, See I, Epson E, et al. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States. MMWR Morb Mortal Wkly Rep. 2019;68:214–9.

Article  PubMed  PubMed Central  Google Scholar 

Kim S-H, Jeon M, Jang S, Mun SJ. Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: the importance of treatment response rather than bacteremia duration. J Microbiol Immunol Infect. 2023;56:1007–15.

Article  PubMed  CAS  Google Scholar 

Anantha RV, Jegatheswaran J, Pepe DL, Priestap F, Delport J, Haeryfar SMM, et al. Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study. CMAJ Open. 2014;2:E352–9.

Article  PubMed  PubMed Central  Google Scholar 

Youngster I, Shenoy ES, Hooper DC, Nelson SB. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis. 2014;59:369–75.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rao SN, Rhodes NJ, Lee BJ, Scheetz MH, Hanson AP, Segreti J, et al. Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2015;59:5232–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

McDanel JS, Roghmann M-C, Perencevich EN, Ohl ME, Goto M, Livorsi DJ, et al. Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study. Clin Infect Dis. 2017;65:100–6.

Article  PubMed  Google Scholar 

Kim S-H, Kim K-H, Kim H-B, Kim N-J, Kim E-C, Oh M, et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2008;52:192–7.

Article  PubMed  CAS  Google Scholar 

Agnello S, Wardlow LC, Reed E, Smith JM, Coe K, Day SR. Clinical outcomes of daptomycin versus anti-staphylococcal beta-lactams in definitive treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections. Int J Antimicrob Agents. 2021;58:106363.

Article  PubMed  CAS  Google Scholar 

Bidell MR, Patel N, O’Donnell JN. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. J Antimicrob Chemother. 2018;73:2643–51.

Article  PubMed  CAS  Google Scholar 

Weis S, Kesselmeier M, Davis JS, Morris AM, Lee S, Scherag A, et al. Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2019;25:818–27.

Article  PubMed  CAS  Google Scholar 

Schmidt-Hellerau K, Breuninger M, Kessel J, Vehreschild MJGT, Paul G, Reusch J, et al. Flucloxacillin and cefazolin for treatment of Staphylococcus aureus bloodstream infection. Infection. 2024;52:1159–63.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Smelter AA, Frei CR, Smelter DF. Successful clearance of persistent Staphylococcus aureus pneumonia with high-dose continuous infusion cefazolin. ASM Case Reports. 2025;1:e00114-24.

Article  PubMed  PubMed Central  Google Scholar 

Lee SO, Lee S, Park S, Lee JE, Lee SH. In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin. J Antimicrob Chemother. 2025;80:1287–90.

Article  PubMed  CAS  Google Scholar 

Dingle TC, Gamage D, Gomez-Villegas S, Hanson BM, Reyes J, Abbott A, et al. Prevalence and characterization of the cefazolin inoculum effect in North American methicillin-susceptible Staphylococcus aureus isolates. J Clin Microbiol. 2022;60:e02495-21.

Article  PubMed  PubMed Central  Google Scholar 

Nannini EC, Stryjewski ME, Singh KV, Bourgogne A, Rude TH, Corey GR, et al. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother. 2009;53:3437–41.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bourreau A, Le Mabecque V, Broquet A, Caillon J. Prevalence of a cefazolin inoculum effect associated with blaZ gene types, and clinical outcomes among methicillin-susceptible Staphylococcus aureus blood isolates of patients with infective endocarditis. Infectious Diseases Now. 2023;53:104626.

Article  PubMed  CAS  Google Scholar 

Lo CK-F, Sritharan A, Zhang J, Li N, Zhang C, Wang F, et al. Clinical significance of cefazolin inoculum effect in serious MSSA infections: a systematic review. JAC-Antimicrobial Resistance. 2024;6:dlae069.

Article  PubMed  PubMed Central  Google Scholar 

McNeil JC, Sommer LM, Boyle M, Hogan P, Vallejo JG, Hultén KG, et al. Cefazolin inoculum effect and methicillin-susceptible Staphylococcus aureus osteoarticular infections in children. Antimicrob Agents Chemother. 2020;64:e00703-20.

Article  PubMed  PubMed Central  Google Scholar 

Miller WR, Seas C, Carvajal LP, Diaz L, Echeverri AM, Ferro C, et al. The cefazolin inoculum effect is associated with increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia. Open Forum Infect Dis. 2018;5:ofy123.

Article  PubMed  PubMed Central  Google Scholar 

Wang SK, Gilchrist A, Loukitcheva A, Plotkin BJ, Sigar IM, Gross AE, et al. Prevalence of a cefazolin inoculum effect associated with blaZ gene types among methicillin-susceptible Staphylococcus aureus isolates from four major medical centers in Chicago. Antimicrob Agents Chemother. 2018;62:e00382-18.

Article  PubMed  PubMed Central  Google Scholar 

Rincon S, Reyes J, Carvajal LP, Rojas N, Cortes F, Panesso D, et al. Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals. J Antimicrob Chemother. 2013;68:2773–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Carvajal LP, Rincon S, Echeverri AM, Porras J, Rios R, Ordoñez KM, et al. Novel insights into the classification of staphylococcal β-lactamases in relation to the cefazolin inoculum effect. Antimicrob Agents Chemother. 2020;64:e02511-19.

Article  PubMed  PubMed Central  Google Scholar 

Carvajal LP, Rincon S, Gomez Villegas SI, Matiz-Gonzalez JM, Ordoñez K, Santamaria A, et al. Prevalence of the cefazolin inoculum effect (CzIE) in nasal colonizing methicillin-susceptible Staphylococcus aureus in patients from intensive care units in Colombia and use of a modified rapid nitrocefin test for detection. Antimicrob Agents Chemother. 2024;68:e00898-24.

Article  PubMed  PubMed Central